Biological Assembly 1  

 3D View: Structure

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors.

Macromolecule Content

• Total Structure Weight: 16.56 kDa 
• Atom Count: 921 
• Residue Count: 112 
• Unique protein chains: 1

2M8T

Solution NMR structure of the V209M variant of the human prion protein (residues 90-231)

• DOI: 10.2210/pdb2M8T/pdb
• BMRB: 19268

• Classification: CELL CYCLE
• Organism(s): Homo sapiens
• Expression System: Escherichia coli
• Mutation(s): Yes 


• Deposited: 2013-05-28 Released: 2013-09-11 
• Deposition Author(s): Mills, J.L., Surewicz, K., Surewicz, W., Soennichsen, F.D.

---

Experimental Data Snapshot

• Method: SOLUTION NMR
• Conformers Calculated: 100 
• Conformers Submitted: 20 
• Selection Criteria: structures with the least restraint violations 

Literature

Thermodynamic Stabilization of the Folded Domain of Prion Protein Inhibits Prion Infection in Vivo.

Kong, Q., Mills, J.L., Kundu, B., Li, X., Qing, L., Surewicz, K., Cali, I., Huang, S., Zheng, M., Swietnicki, W., Sonnichsen, F.D., Gambetti, P., Surewicz, W.K.

(2013) Cell Rep 4: 248-254

• PubMed: 23871665 
• DOI: 10.1016/j.celrep.2013.06.030
• Primary Citation of Related Structures:  
  2M8T


• PubMed Abstract: 
  

Prion diseases, or transmissible spongiform encephalopathies (TSEs), are associated with the conformational conversion of the cellular prion protein, PrP(C), into a protease-resistant form, PrP(Sc). Here, we show that mutation-induced thermodynamic stabilization of the folded, α-helical domain of PrP(C) has a dramatic inhibitory effect on the conformational conversion of prion protein in vitro, as well as on the propagation of TSE disease in vivo. Transgenic mice expressing a human prion protein variant with increased thermodynamic stability were found to be much more resistant to infection with the TSE agent than those expressing wild-type human prion protein, in both the primary passage and three subsequent subpassages. These findings not only provide a line of evidence in support of the protein-only model of TSEs but also yield insight into the molecular nature of the PrP(C)→PrP(Sc) conformational transition, and they suggest an approach to the treatment of prion diseases.

---

Organizational Affiliation: 

Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA. [e-mail]

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Major prion protein	A	146	Homo sapiens	Mutation(s): 1  Gene Names: PRIP, PRNP, PRP, ALTPRP
Find proteins for P04156 (Homo sapiens) Explore P04156  Go to UniProtKB:  P04156
NIH Common Fund Data Resources
PHAROS:  P04156 GTEx:  ENSG00000171867

Experimental Data & Validation

Experimental Data

• Method: SOLUTION NMR
• Conformers Calculated: 100 
• Conformers Submitted: 20 
• Selection Criteria: structures with the least restraint violations 
• OLDERADO: 2M8T Olderado

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2013-05-28 
• Released Date: 2013-09-11 
Deposition Author(s): Mills, J.L., Surewicz, K., Surewicz, W., Soennichsen, F.D.

Revision History 

• Version 1.0: 2013-09-11
  Type: Initial release